查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587154

臨床試驗患者招募服務市場：按治療領域、階段和年齡層別分類 - 全球預測 2025-2030

Clinical Trial Patient Recruitment Services Market by Therapeutic Areas (Anti-Infective, Cardiovascular, Central Nervous System), Phase (Phase I, Phase II, Phase Ill), Age Group - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年臨床試驗患者招募服務市值為11.6億美元，預計到2024年將達到12.7億美元，複合年成長率為9.63%，到2030年將達到22.2億美元。

臨床試驗患者招募服務的研究範圍包括確定、參與和招募合適受試者進行臨床試驗的策略和工作，這是製藥和醫學研究領域的重要組成部分。日益複雜的試驗設計、嚴格的監管要求以及需要多樣化的參與者池以確保試驗結果的廣泛適用性都需要這些服務。典型應用包括病患人口統計、推廣宣傳活動、預篩檢和後勤規劃。最終用途領域主要是製藥公司、委外研發機構(CRO) 和學術機構。該市場是由全球臨床試驗數量不斷增加、個人化醫療需求不斷成長以及數位健康技術的採用等因素所推動的。此外，COVID-19 大流行加速了遠端和分散臨床試驗的創新，為提供患者招募技術解決方案（例如人工智慧主導的分析和虛擬登記工具）的公司創造了機會。然而，市場成長受到嚴格的資料隱私法、營運成本和參與者保留問題等挑戰的阻礙。學術研究和小型製藥公司的財務限制也是一個主要障礙。業務發展的創新領域包括開發機器學習演算法來識別和預測參與者的可用性以及使用社交媒體平台建立病人參與框架。與醫療保健提供者合作，更有效地整合患者資料，可以進一步了解患者的可用性和適用性。這個市場競爭激烈，因此您應該專注於與潛在的臨床試驗參與者和相關人員建立信任和透明度。利用技術最佳化成本、簡化招募和加強溝通的公司將獲得競爭優勢。建議包括投資客製化數位平台以完善患者定位技術，並與高科技公司和醫療保健網路建立策略夥伴關係，以提高招募效率並擴大候選人庫。

主要市場統計
基準年[2023] 11.6億美元
預測年份 [2024] 12.7億美元
預測年份 [2030] 22.2億美元
複合年成長率（%） 9.63%

市場動態：針對快速發展的臨床試驗患者招募服務市場揭示的關鍵市場洞察

供需的動態交互作用正在改變臨床試驗患者招募服務市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球臨床試驗數量增加
    • 臨床試驗組織快速採用病患招募服務
    • 政府對病患參與計畫的支持
  • 市場限制因素
    • 對公關服務高成本的擔憂
  • 市場機會
    • 製藥和生物技術領域的持續研發活動
    • 共同努力促進臨床試驗患者招募服務的成長
  • 市場挑戰
    • 患者缺乏對臨床試驗的認知

波特五力：駕馭臨床試驗病患招募服務市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解臨床試驗病患招募服務市場的外部影響

外部宏觀環境因素在塑造臨床試驗患者招募服務市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解臨床試驗病患招募服務市場的競爭狀況

臨床試驗患者招募服務市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣臨床試驗病患招募服務市場供應商的績效評估

FPNV 定位矩陣是評估臨床試驗病患招募服務市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃臨床試驗病患招募服務市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對臨床試驗患者招募服務市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的臨床試驗不斷增加
      • 臨床試驗機構快速引進病患招募服務
      • 政府對病患參與計畫的支持
    • 抑制因素
      • 對公關服務成本高的擔憂
    • 機會
      • 製藥和生物技術領域的持續研發活動
      • 共同努力加速臨床試驗患者招募服務的成長
    • 任務
      • 患者對臨床試驗缺乏認知
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依治療領域分類的臨床試驗病患招募服務市場

  • 抗感染
  • 心血管
  • 中樞神經系統
  • 內分泌
  • 腫瘤學
  • 疼痛和麻醉
  • 呼吸系統疾病

第7章臨床試驗病患招募服務市場分階段

  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第8章臨床試驗病患招募服務市場：依年齡層

  • 成人用
  • 孩子

第9章美洲臨床試驗病患招募服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太臨床試驗病患招募服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲臨床試驗病患招募服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Antidote Technologies, Inc.
  • AutoCruitment LLC by QHP Capital
  • BBK Worldwide, LLC
  • Biorasi, LLC
  • Clara Health by M&B Sciences Inc.
  • Clariness GmbH
  • Clinical Site Services（CCSi）
  • Conduent, Inc.
  • Elligo Health Research
  • IQVIA Inc. by Q2 Metrics
  • Matthews Media Group Inc.
  • MESM Ltd by VWR
  • PatientEvolution
  • PPD Inc. by Thermo Fisher Scientific
  • Science 37, Inc. by LifeSci Acquisition II Corp.
  • Syneos Health
  • Trialbee AB
  • Trialfacts
  • Veristat
  • Worldwide Clinical Trials
Product Code: MRR-8C74ADFBFBFA

The Clinical Trial Patient Recruitment Services Market was valued at USD 1.16 billion in 2023, expected to reach USD 1.27 billion in 2024, and is projected to grow at a CAGR of 9.63%, to USD 2.22 billion by 2030.

The scope of Clinical Trial Patient Recruitment Services encompasses the strategies and efforts to identify, engage, and enroll suitable participants for clinical trials, a critical component of the pharmaceutical and medical research sectors. These services are necessary due to increasing complexities in trial designs, stringent regulatory requirements, and the need for diverse participant pools to ensure broad applicability of trial results. Key applications include patient demographics identification, outreach campaigns, pre-screening, and logistical planning. End-use sectors primarily involve pharmaceutical companies, contract research organizations (CROs), and academic institutions. The market is driven by factors such as the global rise in clinical trials, growing demand for personalized medicine, and the adoption of digital health technologies. Moreover, the COVID-19 pandemic accelerated innovations in remote and decentralized trials, creating opportunities for companies offering technological solutions in patient recruitment, such as AI-driven analytics and virtual enrollment tools. However, market growth is impeded by challenges like stringent data privacy laws, operational costs, and participant retention issues. Financial constraints in academic research and smaller pharmaceutical firms also pose significant barriers. Innovative areas for business advancement include the development of machine learning algorithms for identification and prediction of participant availability and establishing patient engagement frameworks using social media platforms. Collaboration with healthcare providers to integrate patient data more effectively offers additional insights into patient availability and suitability. The highly competitive nature of this market necessitates a focus on building trust and transparency with potential trial participants and stakeholders. Companies that leverage technology to optimize costs, streamline recruitment, and enhance communication stand to gain a competitive edge. Recommendations include investing in customized digital platforms to refine patient targeting techniques and forming strategic partnerships with tech companies and medical networks to enhance recruitment efficacy and expand the candidate pool.

KEY MARKET STATISTICS
Base Year [2023] USD 1.16 billion
Estimated Year [2024] USD 1.27 billion
Forecast Year [2030] USD 2.22 billion
CAGR (%) 9.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Patient Recruitment Services Market

The Clinical Trial Patient Recruitment Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of clinical trials all over the globe
    • Rapid adoption of patient recruitment sevices by clinical trial organizations
    • Government support for patient engagement programs
  • Market Restraints
    • Concern associated with substantial cost of the PR services
  • Market Opportunities
    • Ongoing research and development activities in pharmaceuticals and biotechnology sector
    • Collaborative efforts to enhance the growth of the clinical trials patient recruitment services
  • Market Challenges
    • Lack of awareness about clinical trials in patients

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Patient Recruitment Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Patient Recruitment Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Patient Recruitment Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Patient Recruitment Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Patient Recruitment Services Market

A detailed market share analysis in the Clinical Trial Patient Recruitment Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Patient Recruitment Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Patient Recruitment Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Trial Patient Recruitment Services Market

A strategic analysis of the Clinical Trial Patient Recruitment Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Patient Recruitment Services Market, highlighting leading vendors and their innovative profiles. These include Antidote Technologies, Inc., AutoCruitment LLC by QHP Capital, BBK Worldwide, LLC, Biorasi, LLC, Clara Health by M&B Sciences Inc., Clariness GmbH, Clinical Site Services (CCSi), Conduent, Inc., Elligo Health Research, IQVIA Inc. by Q2 Metrics, Matthews Media Group Inc., MESM Ltd by VWR, PatientEvolution, PPD Inc. by Thermo Fisher Scientific, Science 37, Inc. by LifeSci Acquisition II Corp., Syneos Health, Trialbee AB, Trialfacts, Veristat, and Worldwide Clinical Trials.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Patient Recruitment Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Therapeutic Areas, market is studied across Anti-Infective, Cardiovascular, Central Nervous System, Endocrine, Oncology, Pain & Anesthesia, and Respiratory Diseases.
  • Based on Phase, market is studied across Phase I, Phase II, Phase Ill, and Phase IV.
  • Based on Age Group, market is studied across Adult and Child.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of clinical trials all over the globe
      • 5.1.1.2. Rapid adoption of patient recruitment sevices by clinical trial organizations
      • 5.1.1.3. Government support for patient engagement programs
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with substantial cost of the PR services
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development activities in pharmaceuticals and biotechnology sector
      • 5.1.3.2. Collaborative efforts to enhance the growth of the clinical trials patient recruitment services
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness about clinical trials in patients
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trial Patient Recruitment Services Market, by Therapeutic Areas

  • 6.1. Introduction
  • 6.2. Anti-Infective
  • 6.3. Cardiovascular
  • 6.4. Central Nervous System
  • 6.5. Endocrine
  • 6.6. Oncology
  • 6.7. Pain & Anesthesia
  • 6.8. Respiratory Diseases

7. Clinical Trial Patient Recruitment Services Market, by Phase

  • 7.1. Introduction
  • 7.2. Phase I
  • 7.3. Phase II
  • 7.4. Phase Ill
  • 7.5. Phase IV

8. Clinical Trial Patient Recruitment Services Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adult
  • 8.3. Child

9. Americas Clinical Trial Patient Recruitment Services Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Clinical Trial Patient Recruitment Services Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Trial Patient Recruitment Services Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Antidote Technologies, Inc.
  • 2. AutoCruitment LLC by QHP Capital
  • 3. BBK Worldwide, LLC
  • 4. Biorasi, LLC
  • 5. Clara Health by M&B Sciences Inc.
  • 6. Clariness GmbH
  • 7. Clinical Site Services (CCSi)
  • 8. Conduent, Inc.
  • 9. Elligo Health Research
  • 10. IQVIA Inc. by Q2 Metrics
  • 11. Matthews Media Group Inc.
  • 12. MESM Ltd by VWR
  • 13. PatientEvolution
  • 14. PPD Inc. by Thermo Fisher Scientific
  • 15. Science 37, Inc. by LifeSci Acquisition II Corp.
  • 16. Syneos Health
  • 17. Trialbee AB
  • 18. Trialfacts
  • 19. Veristat
  • 20. Worldwide Clinical Trials

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PAIN & ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE ILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY CHILD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 150. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET, FPNV POSITIONING MATRIX, 2023